Aspirin Use May Decrease Ventilation, ICU Admission and Death in COVID-19 Patients

GW researchers found that aspirin may have lung-protective effects and reduce in-hospital mortality in hospitalized COVID-19 patients.
March 25, 2021

George Washington University researchers found low dose aspirin may reduce the need for mechanical ventilation, ICU admission and in-hospital mortality in hospitalized COVID-19 patients, according to a new study.

“As we learned about the connection between blood clots and COVID-19, we knew that aspirin—used to prevent stroke and heart attack—could be important for COVID-19 patients,” said Jonathan Chow, assistant professor of anesthesiology and critical care medicine and director of the Critical Care Anesthesiology Fellowship at the GW School of Medicine and Health Sciences. “Our research found an association between low dose aspirin and decreased severity of COVID-19 and death...”

Read the full article on GW Today

Latest News

January 17, 2022
Two recent editorials in the Clinical Journal of the American Society of Nephrology discuss the benefits and drawbacks of telehealth in the context of treating chronic kidney disease now and in the future.
January 3, 2022
From new forms of medicine to less wasteful business practices, many have adapted to Covid-19 in ways that have improved them, and society.
December 15, 2021
As the virulent new omicron variant of the coronavirus emerges, a key component of reducing transmissions and keeping society open is faster and more accurate testing.